SEARCH

SEARCH BY CITATION

References

  • Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS & Bager F (2001) Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 45: 20542059.
  • Al Obeid S, Gutmann L & Williamson R (1990) Modification of penicillin-binding proteins of penicillin-resistant mutants of different species of enterococci. J Antimicrob Chemother 26: 613618.
  • Appelbaum PC (2006) The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect 12 (suppl 1), 1623.
  • Arduino RC, Jacques-Palaz K, Murray BE & Rakita RM (1994) Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect Immun 62: 55875594.
  • Arthur M, Molinas C, Depardieu F & Courvalin P (1993) Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 175: 117127.
  • Arthur M, Reynolds P & Courvalin P (1996) Glycopeptide resistance in enterococci. Trends Microbiol 4: 401407.
  • Baldassarri L, Bertuccini L, Ammendolia MG, Gherardi G & Creti R (2001) Variant esp gene in vancomycin-sensitive Enterococcus faecium. Lancet 357: 1802.
  • Baquero F, Coque TM & Canton R (2003) Antibiotics, complexity, and evolution. ASM News 69: 547552.
  • Barna JC & Williams DH (1984) The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol 38: 339357.
  • Bonora MG, Ligozzi M, De Fatima M, Bragagnolo L, Goglio A, Guazzotti GC & Fontana R (2004) Vancomycin-resistant Enterococcus faecium isolates causing hospital outbreaks in northern Italy belong to the multilocus sequence typing C1 lineage. Microb Drug Resist 10: 114123.
  • Bonten MJ, Hayden MK, Nathan C, Rice TW & Weinstein RA (1998) Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis 177: 378382.
  • Bonten MJ, Willems R & Weinstein RA (2001) Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 1: 314325.
  • Borgen K, Simonsen GS, Sundsfjord A, Wasteson Y, Olsvik O & Kruse H (2000a) Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J Appl Microbiol 89: 478485.
  • Borgen K, Sorum M, Kruse H & Wasteson Y (2000b) Persistence of vancomycin-resistant enterococci (VRE) on Norwegian broiler farms. FEMS Microbiol Lett 191: 255258.
  • Borgen K, Sorum M, Wasteson Y & Kruse H (2001) VanA-type vancomycin-resistant enterococci (VRE) remain prevalent in poultry carcasses 3 years after avoparcin was banned. Int J Food Microbiol 64: 8994.
  • Borgen K, Wasteson Y, Kruse H & Willems RJ (2002) Vancomycin-resistant Enterococcus faecium (VREF) from Norwegian poultry cluster with VREF from poultry from the United Kingdom and the Netherlands in an amplified fragment length polymorphism genogroup. Appl Environ Microbiol 68: 31333137.
  • Bradley CR & Fraise AP (1996) Heat and chemical resistance of enterococci. J Hosp Infect 34: 191196.
  • Brisson-Noel A, Dutka-Malen S, Molinas C, Leclercq R & Courvalin P (1990) Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147. Antimicrob Agents Chemother 34: 924927.
  • Bruinsma N, Willems RJ, Van Den Bogaard AE, Santen-Verheuvel M, London N, Driessen C & Stobberingh EE (2002) Different levels of genetic homogeneity in vancomycin-resistant and -susceptible Enterococcus faecium isolates from different human and animal sources analyzed by amplified-fragment length polymorphism. Antimicrob Agents Chemother 46: 27792783.
  • Carias LL, Rudin SD, Donskey CJ & Rice LB (1998) Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 180: 44264434.
  • Chang S, Sievert DM, Hageman JC et al. (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348: 13421347.
  • Chu G, Vollrath D & Davis RW (1986) Separation of large DNA molecules by contour-clamped homogeneous electric fields. Science 234: 15821585.
  • Coque TM, Tomayko JF, Ricke SC, Okhyusen PC & Murray BE (1996) Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 40: 26052609.
  • Coque TM, Willems R, Canton R, Del Campo R & Baquero F (2002) High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients. J Antimicrob Chemother 50: 10351038.
  • Coque TM, Willems RJ, Fortun J, Top J, Diz S, Loza E, Canton R & Baquero F (2005) Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob Agents Chemother 49: 26932700.
  • Costa Y, Galimand M, Leclercq R, Duval J & Courvalin P (1993) Characterization of the chromosomal aac(6)-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother 37: 18961903.
  • Coudron PE, Mayhall CG, Facklam RR, Spadora AC, Lamb VA, Lybrand MR & Dalton HP (1984) Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol 20: 10441048.
  • Courvalin P (2006) Vancomycin resistance in gram-positive cocci. Clin Infect Dis 42: S25S34.
  • Cremniter J, Mainardi JL, Josseaume N, Quincampoix JC, Dubost L, Hugonnet JE, Marie A, Gutmann L, Rice LB & Arthur M (2006) Novel mechanism of resistance to glycopeptide antibiotics in Enterococcus faecium. J Biol Chem 281: 3225432262.
  • Creti R, Imperi M, Bertuccini L, Fabretti F, Orefici G, Di Rosa R & Baldassarri L (2004) Survey for virulence determinants among Enterococcus faecalis isolated from different sources. J Med Microbiol 53: 1320.
  • Dahl KH, Simonsen GS, Olsvik O & Sundsfjord A (1999) Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci. Antimicrob Agents Chemother 43: 11051110.
  • Dahl KH, Lundblad EW, Rokenes TP, Olsvik O & Sundsfjord A (2000) Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant enterococci and characterization of two novel insertion sequences. Microbiology 146: 14691479.
  • Descheemaeker PR, Chapelle S, Devriese LA, Butaye P, Vandamme P & Goossens H (1999) Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins. Antimicrob Agents Chemother 43: 20322037.
  • Dornbusch K, King A & Legakis N (1998) Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study European Study Group on Antibiotic Resistance (ESGAR). Scand J Infect Dis 30: 281288.
  • Dupre I, Zanetti S, Schito AM, Fadda G & Sechi LA (2003) Incidence of virulence determinants in clinical Enterococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy). J Med Microbiol 52: 491498.
  • EARSS (2004) European Antimicrobial Resistance Surveillance System Annual report 2004 (http://www.earss.rivm.nl).
  • Eaton TJ & Gasson MJ (2001) Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 67: 16281635.
  • Eaton TJ & Gasson MJ (2002) A variant enterococcal surface protein Esp(fm) in Enterococcus faecium; distribution among food, commensal, medical, and environmental isolates. FEMS Microbiol Lett 216: 269275.
  • Facklam RR & Collins MD (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27: 731734.
  • Facklam RR, Carvalho MG & Teixeira LM (2002) Biochemical Characteristics and Antibiotic Susceptibility Testing of Enterococci. The Enterococci; Pathogenesis, Molecular Biology and Antibiotic Resistance (GilmoreMS, ed), pp. 154. ASM Press, Washington.
  • Fontana R, Amalfitano G, Rossi L & Satta G (1992) Mechanisms of resistance to growth inhibition and killing by beta-lactam antibiotics in enterococci. Clin Infect Dis 15: 486489.
  • Fontana R, Aldegheri M, Ligozzi M, Lopez H, Sucari A & Satta G (1994) Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 38: 19801983.
  • Fontana R, Ligozzi M, Mazzariol A, Veneri G & Cornaglia G (1998) Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis 27: S84S86.
  • Fortun J, Coque TM, Martin-Davila P, Moreno L, Canton R, Loza E, Baquero F & Moreno S (2002) Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium. J Antimicrob Chemother 50: 10031009.
  • Freeman R, Kearns AM & Lightfoot NF (1994) Heat resistance of nosocomial enterococci. Lancet 344: 6465.
  • Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, Eisner W, Warren S & Kreiswirth B (1993) Emergence of vancomycin-resistant enterococci in New York City. Lancet 342: 7679.
  • Georgopapadakou NH & Liu FY (1980) Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity. Antimicrob Agents Chemother 18: 834836.
  • Gilmore MS, Coburn PS, Nallapareddy SR & Murray BE (2002) Enterococcal Virulence. The Enterococci; Pathogenesis, Molecular Biology and Antibiotic Resistance (GilmoreMS, ed), pp. 301354. ASM Press, Washington.
  • Goering RV & Winters MA (1992) Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol 30: 577580.
  • Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, Thornsberry C, Jarvis WR & Tenover FC (1992) Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol 30: 23732378.
  • Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, De Girolami PC, Ferraro MJ & Moellering RC Jr (1991) Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 35: 21802184.
  • Guru P (1993) Nosocomial enterococci resistant to vancomycin – United States, 1989–1993. Morb Mortal Wkly Rep 42: 597599.
  • Guru P (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32: 470485.
  • Hammerum AM & Jensen LB (2002) Prevalence of esp, encoding the enterococcal surface protein, in Enterococcus faecalis and Enterococcus faecium isolates from hospital patients, poultry, and pigs in Denmark. J Clin Microbiol 40: 4396.
  • Harthug S, Jureen R, Mohn SC, Digranes A, Simonsen GS, Sundsfjord A & Langeland N (2002) The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals. J Hosp Infect 50: 145154.
  • Heikens E, Bonten MJ & Willems RJ (2007) Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 189: 82338240.
  • Heuer OE, Pedersen K, Jensen LB, Madsen M & Olsen JE (2002) Persistence of vancomycin-resistant enterococci (VRE) in broiler houses after the avoparcin ban. Microb Drug Resist 8: 355361.
  • Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, Van Embden JD & Willems RJ (2002) Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 40: 19631971.
  • Jensen LB, Ahrens P, Dons L, Jones RN, Hammerum AM & Aarestrup FM (1998) Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol 36: 437442.
  • Jensen LB, Willems RJ & Van Den Bogaard AE (2003) Genetic characterization of glycopeptide-resistant enterococci of human and animal origin from mixed pig and poultry farms. APMIS 111: 669672.
  • Johnsen PJ, Osterhus JI, Sletvold H, Sorum M, Kruse H, Nielsen K, Simonsen GS & Sundsfjord A (2005) Persistence of animal and human glycopeptide-resistant enterococci on two Norwegian poultry farms formerly exposed to avoparcin is associated with a widespread plasmid-mediated vanA element within a polyclonal Enterococcus faecium population. Appl Environ Microbiol 71: 159168.
  • Jones RN, Sader HS, Erwin ME & Anderson SC (1995) Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group. Diagn Microbiol Infect Dis 21: 8593.
  • Jureen R, Top J, Mohn SC, Harthug S, Langeland N & Willems RJ (2003) Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway. J Clin Microbiol 41: 23302336.
  • Jureen R, Harthug S, Sornes S, Digranes A, Willems RJ & Langeland N (2004) Comparative analysis of amplified fragment length polymorphism and pulsed field gel electrophoresis in a hospital outbreak and subsequent endemicity of ampicillin-resistant Enterococcus faecium. FEMS Immunol Med Microbiol 40: 3339.
  • Kak V & Chow JW (2002) Acquired antibiotic resistance in Enterococci. The Enterococci; Pathogenesis, Molecular Biology and Antibiotic Resistance (GilmoreMS, ed), pp. 355383. ASM Press, Washington.
  • Kearns AM, Freeman R & Lightfoot NF (1995) Nosocomial enterococci: resistance to heat and sodium hypochlorite. J Hosp Infect 30: 193199.
  • Kim WJ, Weinstein RA & Hayden MK (1999) The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 179: 163171.
  • Kirst HA, Thompson DG & Nicas TI (1998) Historical yearly usage of vancomycin. Antimicrob Agents Chemother 42: 13031304.
  • Klare I, Rodloff AC, Wagner J, Witte W & Hakenbeck R (1992) Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 36: 783787.
  • Klare I, Badstubner D, Konstabel C, Bohme G, Claus H & Witte W (1999) Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 5: 4552.
  • Klare I, Konstabel C, Mueller-Bertling S et al. (2005) Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 24: 815825.
  • Ko KS, Baek JY, Lee JY, Oh WS, Peck KR, Lee N, Lee WG, Lee K & Song JH (2005) Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea. J Clin Microbiol 43: 23032306.
  • Lavery A, Rossney AS, Morrison D, Power A & Keane CT (1997) Incidence and detection of multi-drug-resistant enterococci in Dublin hospitals. J Med Microbiol 46: 150156.
  • Leavis H, Top J, Shankar N, Borgen K, Bonten M, Van Embden J & Willems RJ (2004) A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 186: 672682.
  • Leavis HL, Willems RJ, Van Wamel WJ, Schuren FH, Caspers MP & Bonten MJ (2007) Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog 3: e7.
  • Leclercq R, Derlot E, Duval J & Courvalin P (1988) Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319: 157161.
  • Lee WG, Lee SM & Kim YS (2006) Molecular characterization of Enterococcus faecium isolated from hospitalized patients in Korea. Lett Appl Microbiol 43: 274279.
  • Ligozzi M, Pittaluga F & Fontana R (1996) Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 40: 354357.
  • Lopes MF, Simoes AP, Tenreiro R, Marques JJ & Crespo MT (2006) Activity and expression of a virulence factor, gelatinase, in dairy enterococci. Int J Food Microbiol 112: 208214.
  • Low DE, Keller N, Barth A & Jones RN (2001) Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 32: S133S145.
  • Luginbuhl LM, Rotbart HA, Facklam RR, Roe MH & Elliot JA (1987) Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J 6: 10221026.
  • Maiden MC, Bygraves JA, Feil E et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95: 31403145.
  • Mainardi JL, Legrand R, Arthur M, Schoot B, Van Heijenoort J & Gutmann L (2000) Novel mechanism of beta-lactam resistance due to bypass of dd-transpeptidation in Enterococcus faecium. J Biol Chem 275: 1649016496.
  • Mainardi JL, Morel V, Fourgeaud M, Cremniter J, Blanot D, Legrand R, Frehel C, Arthur M, Van Heijenoort J & Gutmann L (2002) Balance between two transpeptidation mechanisms determines the expression of beta-lactam resistance in Enterococcus faecium. J Biol Chem 277: 3580135807.
  • Manson JM, Smith JM & Cook GM (2004) Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use. Appl Environ Microbiol 70: 57645768.
  • Mascini EM, Troelstra A, Beitsma M et al. (2006) Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 42: 739746.
  • Moellering RC Jr & Weinberg AN (1971) Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest 50: 25802584.
  • Morrison D, Woodford N, Barrett SP, Sisson P & Cookson BD (1999) DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J Clin Microbiol 37: 10841091.
  • Moy TI, Mylonakis E, Calderwood SB & Ausubel FM (2004) Cytotoxicity of hydrogen peroxide produced by Enterococcus faecium. Infect Immun 72: 45124520.
  • Mundy LM, Sahm DF & Gilmore M (2000) Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev 13: 513522.
  • Murray BE (1990) The life and times of the Enterococcus. Clin Microbiol Rev 3: 4665.
  • Murray BE (2000) Vancomycin-resistant enterococcal infections. N Engl J Med 342: 710721.
  • Murray BE, Church DA, Wanger A, Zscheck K, Levison ME, Ingerman MJ, Abrutyn E & Mederski-Samoraj B (1986) Comparison of two beta-lactamase-producing strains of Streptococcus faecalis. Antimicrob Agents Chemother 30: 861864.
  • Murray BE, An FY & Clewell DB (1988) Plasmids and pheromone response of the beta-lactamase producer Streptococcus (Enterococcus) faecalis HH22. Antimicrob Agents Chemother 32: 547551.
  • Murray BE, Singh KV, Heath JD, Sharma BR & Weinstock GM (1990) Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 28: 20592063.
  • Nallapareddy SR, Weinstock GM & Murray BE (2003) Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol 47: 17331747.
  • Nallapareddy SR, Singh KV & Murray BE (2006) Construction of improved temperature-sensitive and mobilizable vectors and their use for constructing mutations in the adhesin-encoding acm gene of poorly transformable clinical Enterococcus faecium strains. Appl Environ Microbiol 72: 334345.
  • Neu HC (1987) Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams. Curr Clin Top Infect Dis 8: 3761.
  • Noble CJ (1978) Carriage of group D streptococci in the human bowel. J Clin Pathol 31: 11821186.
  • Oppenheim BA (1998) The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 41 (suppl D), 711.
  • Patel R, Uhl JR, Kohner P, Hopkins MK, Steckelberg JM, Kline B & Cockerill FR III (1998) DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates. Antimicrob Agents Chemother 42: 202205.
  • Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J & Lyons RW (1995) An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74: 191200.
  • Qin X, Singh KV, Weinstock GM & Murray BE (2000) Effects of Enterococcus faecalisfsr genes on production of gelatinase and a serine protease and virulence. Infect Immun 68: 25792586.
  • Qin X, Singh KV, Weinstock GM & Murray BE (2001) Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J Bacteriol 183: 33723382.
  • Quintiliani R Jr, Evers S & Courvalin P (1993) The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis 167: 12201223.
  • Reynolds PE (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8: 943950.
  • Reynolds PE & Courvalin P (2005) Vancomycin resistance in enterococci due to synthesis of precursors terminating in d-alanyl-d-serine. Antimicrob Agents Chemother 49: 2125.
  • Rice LB (2006) Antimicrobial resistance in gram-positive bacteria. Am J Infect Control 34: S11S19.
  • Rice LB, Carias L, Rudin S, Vael C, Goossens H, Konstabel C, Klare I, Nallapareddy SR, Huang W & Murray BE (2003) A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 187: 508512.
  • Ruiz-Garbajosa P, Bonten MJ, Robinson DA et al. (2006) Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 44: 22202228.
  • Ruoff KL, De La ML, Murtagh MJ, Spargo JD & Ferraro MJ (1990) Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 28: 435437.
  • Rybkine T, Mainardi JL, Sougakoff W, Collatz E & Gutmann L (1998) Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance. J Infect Dis 178: 159163.
  • Sahm DF, Marsilio MK & Piazza G (1999) Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database – USA. Clin Infect Dis 29: 259263.
  • Schouten MA, Hoogkamp-Korstanje JA, Meis JF & Voss A (2000) Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19: 816822.
  • Schouten MA, Willems RJ, Kraak WA, Top J, Hoogkamp-Korstanje JA & Voss A (2001) Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother 45: 986989.
  • Sghir A, Gramet G, Suau A, Rochet V, Pochart P & Dore J (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66: 22632266.
  • Shankar V, Baghdayan AS, Huycke MM, Lindahl G & Gilmore MS (1999) Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 67: 193200.
  • Shankar N, Lockatell CV, Baghdayan AS, Drachenberg C, Gilmore MS & Johnson DE (2001) Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun 69: 43664372.
  • Shankar N, Baghdayan AS & Gilmore MS (2002) Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature 417: 746750.
  • Simonsen GS, Smabrekke L, Monnet DL et al. (2003) Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J Antimicrob Chemother 51: 323331.
  • Sorum M, Johnsen PJ, Aasnes B, Rosvoll T, Kruse H, Sundsfjord A & Simonsen GS (2006) Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin. Appl Environ Microbiol 72: 516521.
  • Stobberingh E, Van Den BA, London N, Driessen C, Top J & Willems R (1999) Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of the Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 43: 22152221.
  • Suppola JP, Kolho E, Salmenlinna S, Tarkka E, Vuopio-Varkila J & Vaara M (1999) vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality. J Clin Microbiol 37: 39343939.
  • Swaminathan B, Barrett TJ, Hunter SB & Tauxe RV (2001) PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 7: 382389.
  • Swaminathan B, Gerner-Smidt P, Ng LK, Lukinmaa S, Kam KM, Rolando S, Gutierrez EP & Binsztein N (2006) Building PulseNet International: an interconnected system of laboratory networks to facilitate timely public health recognition and response to foodborne disease outbreaks and emerging foodborne diseases. Foodborne Pathog Dis 3: 3650.
  • Tankovic J, Mahjoubi F, Courvalin P, Duval J & Leclerco R (1996) Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene. Antimicrob Agents Chemother 40: 25582561.
  • Tendolkar PM, Baghdayan AS, Gilmore MS & Shankar N (2004) Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun 72: 60326039.
  • Tendolkar PM, Baghdayan AS & Shankar N (2005) The N-terminal domain of enterococcal surface protein, Esp, is sufficient for Esp-mediated biofilm enhancement in Enterococcus faecalis. J Bacteriol 187: 62136222.
  • Teng F, Kawalec M, Weinstock GM, Hryniewicz W & Murray BE (2003) An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E.faecium growth. Infect Immun 71: 50335041.
  • Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH & Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 22332239.
  • Thouverez M & Talon D (2004) Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France. Clin Microbiol Infect 10: 441447.
  • Timmers GJ, Van Der Zwet WC, Simoons-Smit IM, Savelkoul PH, Meester HH, Vandenbroucke-Grauls CM & Huijgens PC (2002) Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol 116: 826833.
  • Toledo-Arana A, Valle J, Solano C, Arrizubieta MJ, Cucarella C, Lamata M, Amorena B, Leiva J, Penades JR & Lasa I (2001) The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol 67: 45384545.
  • Top J, Schouls LM, Bonten MJ & Willems RJ (2004) Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates. J Clin Microbiol 42: 45034511.
  • Top J, Willems R, Blok H, De Regt M, Jalink K, Troelstra A, Goorhuis B & Bonten M (2007) Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect 13: 316319.
  • Torell E, Cars O, Olsson-Liljequist B, Hoffman BM, Lindback J & Burman LG (1999) Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol 37: 35093513.
  • Treitman AN, Yarnold PR, Warren J & Noskin GA (2005) Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 43: 462463.
  • Uttley AH, Collins CH, Naidoo J & George RC (1988) Vancomycin-resistant enterococci. Lancet 1: 5758.
  • Van Belkum A, Van Den BN, Thomassen R, Verbrugh H & Endtz H (1996) Vancomycin-resistant enterococci in cats and dogs. Lancet 348: 10381039.
  • Van Den Bogaard AE, Jensen LB & Stobberingh EE (1997a) Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 337: 15581559.
  • Van Den Bogaard AE, Mertens P, London NH & Stobberingh EE (1997b) High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in the Netherlands: is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother 40: 454456.
  • Van Den Bogaard AE, Bruinsma N & Stobberingh EE (2000) The effect of banning avoparcin on VRE carriage in the Netherlands. J Antimicrob Chemother 46: 146148.
  • Van Den Bogaard AE, Willems R, London N, Top J & Stobberingh EE (2002) Antibiotic resistance of faecal enterococci in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother 49: 497505.
  • Van Den Braak N, Van Belkum A, Van Keulen M, Vliegenthart J, Verbrugh HA & Endtz HP (1998) Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in the Netherlands. J Clin Microbiol 36: 19271932.
  • Van der Auwera P, Pensart N, Korten V, Murray BE & Leclercq R (1996) Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 173: 11291136.
  • Van Der Steen LF, Bonten MJ, Van Kregten E, Harssema-Poot JJ, Willems R & Gaillard CA (2000) Vancomycin-resistant Enterococcus faecium outbreak in a nephrology ward. Ned Tijdschr Geneeskd 144: 25682572.
  • Van Wamel WJ, Hendrickx AP, Bonten MJ, Top J, Posthuma G & Willems RJ (2007) Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation. Infect Immun 75: 924931.
  • Weaver KE, Rice LB & Churchward G (2002) Plasmids and Transposons. The Enterococci; Pathogenesis, Molecular Biology and Antibiotic Resistance (GilmoreMS, ed), pp. 219264. ASM Press, Washington.
  • Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE & Tenover FC (2003) Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302: 15691571.
  • Weigel LM, Donlan RM, Shin DH et al. (2007) High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 51: 231238.
  • Werner G, Klare I, Spencker FB & Witte W (2003a) Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. J Antimicrob Chemother 52: 113115.
  • Werner G, Willems RJ, Hildebrandt B, Klare I & Witte W (2003b) Influence of transferable genetic determinants on the outcome of typing methods commonly used for Enterococcus faecium. J Clin Microbiol 41: 14991506.
  • Werner G, Dahl KH & Willems RJ (2006) Composite elements encoding antibiotic resistance in Enterococcus faecium and Enterococcus faecalis. Drug resistance in Enterococci (KobayashiN, ed), pp. 157208. Research Signpost, Kerala, India.
  • Willems RJ, Top J, Van Den Braak N, Van Belkum A, Mevius DJ, Hendriks G, Santen-Verheuvel M & Van Embden JD (1999) Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 43: 483491.
  • Willems RJ, Top J, Van Den Braak N, Van Belkum A, Endtz H, Mevius D, Stobberingh E, Van Den Bogaard AE & Van Embden JD (2000) Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis 182: 816823.
  • Willems RJ, Homan W, Top J et al. (2001) Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357: 853855.
  • Willems RJ, Top J, Van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H & Bonten MJ (2005) Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11: 821828.
  • Williamson R, Le Bouguenec C, Gutmann L & Horaud T (1985) One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J Gen Microbiol 131: 19331940.
  • Williamson R, Gutmann L, Horaud T, Delbos F & Acar JF (1986) Use of penicillin-binding proteins for the identification of enterococci. J Gen Microbiol 132: 19291937.
  • Witte W (2004) Glycopeptide resistant Staphylococcus. J Vet Med B Infect Dis Vet Public Health 51: 370373.
  • Witte W, Wirth R & Klare I (1999) Enterococci. Chemotherapy 45: 135145.
  • Woodford N, Adebiyi AM, Palepou MF & Cookson BD (1998) Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother 42: 502508.
  • Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS & Schaberg DR (1987) Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med 106: 687691.
  • Zorzi W, Zhou XY, Dardenne O, Lamotte J, Raze D, Pierre J, Gutmann L & Coyette J (1996) Structure of the low-affinity penicillin-binding protein 5 PBP5fm in wild-type and highly penicillin-resistant strains of Enterococcus faecium. J Bacteriol 178: 49484957.